With a new moniker designed to reflect its broader commitment to health care, CVS Health is “positioned for today, preparing for tomorrow,” executives told Wall Street during its 2014 Analyst Day in December.

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

How is CVS Health planning to replace the loss of $2 billion in tobacco sales? By driving core front-end businesses and improving the shopping experience. In fact, CVS/pharmacy has big plans for health and beauty, Helena Foulkes, EVP and president of CVS/pharmacy, told analysts during the company’s Annual Analyst Day on Dec. 16.

Declaring that it is positioned for today and preparing for tomorrow, CVS Health outlined the steps the company is taking to continue to meet the changing needs of payors, providers and customers at its annual Analyst Day in New York City on Tuesday.

The holiday season is the battery category’s best friend. A shift in the consumer electronics industry to built-in rechargeable batteries and the growth of do-it-all smartphones that replace many battery-operated devices has left the category in a slump.

November front-end drug store sales are expected to be comparable to last year while prescriptions dispensed will be up in the low single-digit range, reported Ed Kelly, Credit Suisse research analyst.

The Council for Responsible Nutrition on Wednesday announced that Susan Dentzer, health analyst at PBS NewsHour and senior policy adviser at the Robert Wood Johnson Foundation, will speak during the closing “Breakfast With…” session.

Revising year-end guidance on account of reimbursement rate headwinds, Rite Aid's stock took a hit after reporting second-quarter earnings even though the company beat analysts' consensus estimates for the quarter. The retail pharmacy operation recorded second-quarter profit of $127.8 million, or 13 cents per share, more than doubling FactSet consensus analyst estimate of 6 cents a share, according to a MarketWatch report. And while revenue of $6.5 billion was in line with analyst expectations, Rite Aid topped expected same-store sales growth of 3.3% by recording 4.1% in same-store sales growth.

Unilever revealed this month the new "Take Pride in Your Pregame" program featuring ESPN college football analyst and SEC Network host Jesse Palmer to help guys take pride in their everyday grooming routines.